← Open Payments lookup

NPI 1447874268: Open Payments

NPI 1447874268. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,527 in 87 payments from 13 companies in 2025. Trend: 2023 $346 · 2024 $1,129 · 2025 $2,527

Food & beverage: $2,425Education: $102
CompanyPaymentsAmount
UCB, Inc.11$377
Galderma Laboratories, L.P.9$312
Janssen Biotech, Inc.4$281
ABBVIE INC.15$281
Arcutis Biotherapeutics, Inc.9$246
LEO Pharma Inc.11$239
Novartis Pharmaceuticals Corporation7$238
Incyte Corporation6$185
Regeneron Healthcare Solutions, Inc.8$160
GENZYME CORPORATION3$122

Products named: Bimzelx, NEMLUVIO, DUPIXENT, TREMFYA, Zoryve, ADBRY, SKYRIZI, OPZELURA.